This may be due to diabetic patients presenting 20-50% lower levels of PTH and low bone remodeling, either by hyperglycemia (accumulation of glycation end-products), reduction of insulin growth factor-1 (which stimulates the proliferation of osteoblasts), increased sclerostin, or hormonal changes (gonadal dysfunction)23. The gene discussed is SOST; the disease is Hyperglycemia.